{
    "organizations": [],
    "uuid": "d3d9b01454afa35ff195fa2ad13bc42278ff0009",
    "author": "",
    "url": "https://www.reuters.com/article/brief-biocryst-advancing-potential-treat/brief-biocryst-advancing-potential-treatment-for-rare-and-severely-debilitating-fibrodysplasia-ossificans-progressiva-idUSFWN1P00FN",
    "ord_in_thread": 0,
    "title": "BRIEF-Biocryst Advancing Potential Treatment For Rare And Severely Debilitating Fibrodysplasia Ossificans Progressiva",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 08 AM / in 5 minutes BRIEF-Biocryst Advancing Potential Treatment For Rare And Severely Debilitating Fibrodysplasia Ossificans Progressiva Reuters Staff \nJan 5 (Reuters) - Biocryst Pharmaceuticals Inc: \n* BIOCRYST ADVANCING POTENTIAL TREATMENT FOR RARE AND SEVERELY DEBILITATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA \n* BIOCRYST PHARMACEUTICALS - IND FOR NONCLINICAL DEVELOPMENT OF BCX9250,BCX9499 INITIATED WITH GOAL OF PROGRESSING TO PHASE 1 CLINICAL TRIALS IN H1 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-01-05T13:06:00.000+02:00",
    "crawled": "2018-01-05T13:20:51.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "advancing",
        "potential",
        "treatment",
        "rare",
        "severely",
        "debilitating",
        "fibrodysplasia",
        "ossificans",
        "progressiva",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "biocryst",
        "pharmaceutical",
        "inc",
        "biocryst",
        "advancing",
        "potential",
        "treatment",
        "rare",
        "severely",
        "debilitating",
        "fibrodysplasia",
        "ossificans",
        "progressiva",
        "biocryst",
        "pharmaceutical",
        "ind",
        "nonclinical",
        "development",
        "bcx9250",
        "bcx9499",
        "initiated",
        "goal",
        "progressing",
        "phase",
        "clinical",
        "trial",
        "h1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}